20/20 Biolabs, Inc. (NasdaqCM: AIDX)
Health Care · Health Care Equipment & Supplies · US
$0.36
-3.28% today · -98.4% 1Y
20/20 Biolabs, Inc. (NasdaqCM: AIDX) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $4.79M and employs 14 people.
Over the last twelve months the share price has lost 98.4%, trading between 0.33 and 50.00.
Tweenvest scores 20/20 Biolabs, Inc. across four factors: quality 36/100, value 73/100, growth 74/100. Its strongest factor is growth.
AIDX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.79M
- Revenue (TTM)
- $2.04M
- P/E
- —
- EPS
- -1.00
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $50.00
- 52-week low
- $0.33
- Avg volume (3M)
- —
- Shares outstanding
- 12.77M
- Employees
- 14
- Next earnings
- —
About 20/20 Biolabs, Inc.
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
- ISIN
- US90138K1016
- Founded
- 2000
- Listed since
- Feb 19, 2026
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Neola Medical AB (publ)OM: NEOLA | $5.02M | Skr0.45 | 0.00% |
| Surgical Innovations Group plcAIM: SUN | $4.94M | £0.00 | -5.88% |
| Cambridge Nutritional Sciences plcAIM: CNSL | $4.88M | £0.02 | +10.71% |
| StimCell Energetics Inc.OTCPK: STME | $4.80M | $0.23 | — |
| Intelligent Bio Solutions Inc.NasdaqCM: INBS | $4.63M | $1.52 | -0.65% |
| KMS Medisurgi LimitedBSE: 540468 | $4.58M | Rs— | — |
| Aethlon Medical, Inc.NasdaqCM: AEMD | $4.30M | $5.83 | -3.64% |
| ScandiDos AB (publ)OM: SDOS | $4.28M | Skr0.59 | -1.67% |
Figures last refreshed Oct 11, 2026.